Get started
PHARMASGP HOLDING SEPHARMASGP HOLDING SEPHARMASGP HOLDING SE

PHARMASGP HOLDING SE

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

PSG fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. It distributes its products under the Baldriparan, Formigran, Spalt, Kamol, RubaXX, Restaxil, DESEO, and NERADIN brands. The company was founded in 2012 and is headquartered in Graefelfing, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
PSG has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company